ZA929709B - Method and composition for ameliorating tissue damage due to ischemia and reperfusion - Google Patents

Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Info

Publication number
ZA929709B
ZA929709B ZA9229709A ZA9229709A ZA929709B ZA 929709 B ZA929709 B ZA 929709B ZA 9229709 A ZA9229709 A ZA 9229709A ZA 9229709 A ZA9229709 A ZA 9229709A ZA 929709 B ZA929709 B ZA 929709B
Authority
ZA
South Africa
Prior art keywords
reperfusion
ischemia
composition
tissue damage
damage due
Prior art date
Application number
ZA9229709A
Other languages
English (en)
Inventor
Gary T Elliott
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ZA929709B publication Critical patent/ZA929709B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA9229709A 1991-12-31 1992-01-01 Method and composition for ameliorating tissue damage due to ischemia and reperfusion ZA929709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/815,250 US5286718A (en) 1991-12-31 1991-12-31 Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Publications (1)

Publication Number Publication Date
ZA929709B true ZA929709B (en) 1993-06-14

Family

ID=25217292

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9229709A ZA929709B (en) 1991-12-31 1992-01-01 Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Country Status (10)

Country Link
US (1) US5286718A (xx)
EP (2) EP0660719B1 (xx)
JP (1) JPH07503709A (xx)
KR (1) KR0156597B1 (xx)
AU (1) AU657037B2 (xx)
DE (1) DE69232033T2 (xx)
ES (1) ES2160592T3 (xx)
NZ (1) NZ245448A (xx)
WO (1) WO1993012778A1 (xx)
ZA (1) ZA929709B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747296A (en) * 1992-05-11 1998-05-05 Corvas International, Inc. Method of detecting neutophil inhibitory factor mimics
AU6475796A (en) * 1995-05-31 1996-12-18 University Of Alabama At Birmingham Research Foundation, The Monoclonal and polyclonal antibodies against recombinant hum an xanthine oxidase, method for their use and a kit containi ng same
JP3604467B2 (ja) * 1995-09-27 2004-12-22 株式会社東芝 心筋のねじれ補正方法
US6348567B1 (en) * 1995-12-06 2002-02-19 Cv Molecular Therapeutics Inc. Peptides and their use to ameliorate cell death
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
US6013640A (en) * 1998-08-21 2000-01-11 Ribi Immunochem Research, Inc. Phosphoglycolipid and methods for its use
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
WO2006063091A2 (en) * 2004-12-06 2006-06-15 Ronald Freudenberger Use of oxypurinol as an inhibitor of anti-neoplastic agent-induced cardiotoxicity
ES2673046T3 (es) 2006-09-26 2018-06-19 Infectious Disease Research Institute Composición de vacuna que contiene un adyuvante sintético
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
CA2764374C (en) 2009-06-05 2019-11-19 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants
CN103596586A (zh) 2011-04-08 2014-02-19 免疫设计公司 免疫原性组合物及使用所述组合物诱导体液和细胞免疫反应的方法
EP2717680A1 (en) 2011-06-09 2014-04-16 Lifeline Scientific, Inc. Data record for organ transport and/or storage, comprising biomarker and events information
CN107540730B (zh) 2012-05-16 2021-07-16 免疫设计公司 用于hsv-2的疫苗
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
US4985241A (en) * 1986-11-21 1991-01-15 Cetus Corporation Therapeutic combination of free-radical scavenger and tumor necrosis factor
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation

Also Published As

Publication number Publication date
NZ245448A (en) 1997-08-22
WO1993012778A1 (en) 1993-07-08
EP0660719B1 (en) 2001-08-29
KR940703658A (ko) 1994-12-12
DE69232033T2 (de) 2002-06-06
KR0156597B1 (ko) 1998-11-16
US5286718A (en) 1994-02-15
ES2160592T3 (es) 2001-11-16
AU3272293A (en) 1993-07-28
EP1068869A2 (en) 2001-01-17
EP0660719A4 (en) 1995-03-02
JPH07503709A (ja) 1995-04-20
EP0660719A1 (en) 1995-07-05
AU657037B2 (en) 1995-02-23
DE69232033D1 (de) 2001-10-04
EP1068869A3 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
ZA929709B (en) Method and composition for ameliorating tissue damage due to ischemia and reperfusion
GB2220319B (en) Improvements in or relating to image stabilisation
GB8814843D0 (en) Improvements in & relating to gaskets
GB8825197D0 (en) Improvements in & relating to gaskets
GB2203805B (en) Improvements in and relating to cylinder head gaskets
GB8811883D0 (en) Improvements in & relating to overvoltage protectors
GB2278819B (en) Improvements in or relating to carriers
ZA955865B (en) The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
GB8900924D0 (en) Compositions for use in enzyme deficiencies
GB9323941D0 (en) Improvements in or relating to clamping devices
EP0344708A3 (en) Composition for external application to skin
GB9107599D0 (en) Improvements in and relating to sealing compositions
EP0446124A3 (en) Use of antiprogestomimetics to synchronise parturition in livestock
GB8815710D0 (en) Improvements in & relating to curtainsided trailers
GB9105092D0 (en) Improvements in and relating to floating structures
GB2252354B (en) Improvements in or relating to clamp assemblies
GB2252355B (en) Improvements in or relating to clamp assemblies
GB8819746D0 (en) Improvements in/relating to nozzles
IL105005A0 (en) Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect
AU590506B3 (en) Improvements in and relating to bow ties
GB8812414D0 (en) Improvements in/relating to growth suppressors
GB9208192D0 (en) Improvements in or relating to divan beds
GB9121903D0 (en) Improvements in or relating to hats
RO93513B1 (ro) Procedeu de obtinere a unui vaccin viu atenuat destinat imunizarii ovinelor contra parainfluentei tip 3
GB8909373D0 (en) Improvements in or relating to growth suppressors